Endocrine Abstracts

Objective: Higher obesity rates are related with increased non-alcoholic fatty liver disease (NAFLD) prevalence which may progress further to non-alcoholic steatohepatitis (NASH) and cirrhosis. The utility of Fibroscan was shown in stratifying risk for significant liver disease. The aim of the study was to evaluate the relation between body mass index (BMI) and liver stiffness measurements (LSM) in overweight and obese patients.Methods: We conducted the ...